Effect of Bleeding Risk on Type of Stent Used in Patients Presenting with Acute Coronary Syndrome

Patients at high bleeding risk (HBR) are at increased risk of bleeding following percutaneous coronary intervention (PCI) with drug-eluting stent (DES) due to the need for longer dual antiplatelet duration. We sought to evaluate the likelihood of receiving DES during PCI in HBR populations and to characterize DES utilization trends over time. Consecutive patients who underwent PCI from April 2003 to September 2015 were identified. HBR is defined as patients fulfilling one or more of the HBR criteria: age ≥75 years, anticoagulation use at discharge, history of stroke, cancer in previous 3 years, glucocorticoid use, hemoglobin (Hgb) (Source: The American Journal of Cardiology)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2uTWiis
via IFTTT